INVO BioScience

INVO53

Penny Stock

$0.83arrow_drop_down2.91%-$0.02

Penny Stock

INVO53

$0.83

arrow_drop_down2.91%-$0.02

Penny Stock

Performance History

Key Stats
Open	$0.86
Prev. Close	$0.85
EPS	0.69
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$3.25M

	LOW	HIGH
Day Range	0.81	0.87
52 Week Range	0.50	3.50

Ratios







EPS	0.69

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About INVO BioScience (INVO)

INVO BioScience, Inc. (INVO) is a company that specializes in the development and commercialization of medical devices for the infertility market. The company's flagship product is the INVOcell, a novel and patented medical device that allows for the incubation of eggs and sperm inside the woman's body, offering a more natural and cost-effective alternative to traditional IVF procedures. The INVOcell has been successfully used by thousands of couples around the world, with impressive success rates and high patient satisfaction.

The stock price history of INVO BioScience, Inc. (INVO) has shown an upward trend over the past few years. The company's stock has experienced significant growth, reflecting the market's recognition of the potential of the INVOcell and the company's overall business strategy. Investors have been optimistic about the company's prospects, and this has translated into a steady increase in the stock price.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Steven M. Shum
Headquarters: Sarasota
Employees: 15
Exchange: NASDAQ

Keep an eye on INVO BioScience

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is INVO BioScience's (INVO) price per share?

The current price per share for INVO BioScience (INVO) is $0.83. The stock has seen a price change of -$0.03 recently, indicating a -2.91% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for INVO BioScience (INVO)?

For INVO BioScience (INVO), the 52-week high is $3.5, which is 320.17% from the current price. The 52-week low is $0.5, the current price is 66.6% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is INVO BioScience (INVO) a growth stock?

INVO BioScience (INVO) has shown an average price growth of -6.8% over the past three years. It has received a score of -2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying INVO BioScience as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is INVO BioScience (INVO) stock price performance year to date (YTD)?

As of the latest data, INVO BioScience (INVO) has a year-to-date price change of -34.92%. Over the past month, the stock has experienced a price change of -7.44%. Over the last three months, the change has been 3.09%. Over the past six months, the figure is -15.43%.

help

Is INVO BioScience (INVO) a profitable company?

INVO BioScience (INVO) has a net income of -$8.03M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 35.96% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -103.61% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $3.02M, although specific revenue growth data is currently not available. The gross profit is $1.09M. Operating income is noted at -$6.77M. Furthermore, the EBITDA is -$4.62M.

help

What is the market capitalization of INVO BioScience (INVO)?

INVO BioScience (INVO) has a market capitalization of $3.25M. The average daily trading volume is 0.85, indicating the stock's liquidity and investor engagement.